INSULIN GLARGINE-YFGN
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for INSULIN GLARGINE-YFGN, covering 2023-05-30 to 2023-11-29. Get the full timeline:
Most recent: FDA Approved: INSULIN GLARGINE — Supplemental Application (Biocon Biologics Inc.)